Abstract: The present invention relates to novel triazene compounds, to a process for their preparation, to pharmaceutical compositions comprising them, and to the use thereof in the treatment of cancer diseases in humans. The novel triazene compounds are distinguished, as compared with the known triazene compounds, by improved activity while at the same time having reduced toxicity, that is to say by fewer side-effects.
Type:
Grant
Filed:
August 9, 2011
Date of Patent:
April 23, 2013
Assignee:
Trin Therapeutics GmbH
Inventors:
Rudolf Reiter, Jochen Kalbe, Heinz Forster
Abstract: The present invention relates to novel triazene compounds, to a process for their preparation, to pharmaceutical compositions comprising them, and to the use thereof in the treatment of cancer diseases in humans. The novel triazene compounds are distinguished, as compared with the known triazene compounds, by improved activity while at the same time having reduced toxicity, that is to say by fewer side-effects.
Type:
Application
Filed:
August 9, 2011
Publication date:
February 2, 2012
Applicant:
TRIN THERAPEUTICS GMBH
Inventors:
Rudolf Reiter, Jochen Kalbe, Heinz Forster
Abstract: The present invention relates to novel triazene compounds, to a process for their preparation, to pharmaceutical compositions comprising them, and to the use thereof in the treatment of cancer diseases in humans. The novel triazene compounds are distinguished, as compared with the known triazene compounds, by improved activity while at the same time having reduced toxicity, that is to say by fewer side-effects.
Type:
Grant
Filed:
July 3, 2008
Date of Patent:
October 11, 2011
Assignee:
Trin Therapeutics GmbH
Inventors:
Rudolf Reiter, Jochen Kalbe, Heinz Forster